Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Development of a Rapid Agglutination Latex Test for Diagnosis of Enteropathogenic and Enterohemorrhagic Escherichia coli Infection in Developing World: Defining the Biomarker, Antibody and Method

Full text
Author(s):
Rocha, Leticia B. [1] ; Santos, Anna R. R. [1] ; Munhoz, Danielle D. [1] ; Cardoso, Lucas T. A. [1] ; Luz, Daniela E. [1] ; Andrade, Fernanda B. [1] ; Horton, Denise S. P. Q. [1] ; Elias, Waldir P. [1] ; Piazza, Roxane M. F. [1]
Total Authors: 9
Affiliation:
[1] Inst Butantan, Lab Bacteriol, Sao Paulo - Brazil
Total Affiliations: 1
Document type: Journal article
Source: PLoS Neglected Tropical Diseases; v. 8, n. 9 SEP 2014.
Web of Science Citations: 7
Abstract

Background: Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) are human intestinal pathogens responsible for diarrhea in both developing and industrialized countries. In research laboratories, EPEC and EHEC are defined on the basis of their pathogenic features; nevertheless, their identification in routine laboratories is expensive and laborious. Therefore, the aim of the present work was to develop a rapid and simple assay for EPEC/EHEC detection. Accordingly, the EPEC/EHEC-secreted proteins EspA and EspB were chosen as target antigens. Methodology: First, we investigated the ideal conditions for EspA/EspB production/secretion by ELISA in a collection of EPEC/EHEC strains after cultivating bacterial isolates in Dulbecco's modified Eagle's medium (DMEM) or DMEM containing 1% tryptone or HEp-2 cells-preconditioned DMEM, employing either anti-EspA/anti-EspB polyclonal or monoclonal antibodies developed and characterized herein. Subsequently, a rapid agglutination latex test (RALT) was developed and tested with the same collection of bacterial isolates. Principal findings: EspB was defined as a biomarker and its corresponding monoclonal antibody as the tool for EPEC/EHEC diagnosis; the production of EspB was better in DMEM medium. RALT assay has the sensitivity and specificity required for high-impact diagnosis of neglected diseases in the developing world. Conclusion: RALT assay described herein can be considered an alternative assay for diarrhea diagnosis in low-income countries since it achieved 97% sensitivity, 98% specificity and 97% efficiency. (AU)

FAPESP's process: 09/14845-7 - Immunodiagnosis of diarrheagenic Escherichia coli
Grantee:Roxane Maria Fontes Piazza
Support type: Regular Research Grants
FAPESP's process: 12/02618-9 - Validation of an immunochromatographic assay for the diagnosis of Diarrheagenic Escherichia coli
Grantee:Anna Raquel Ribeiro dos Santos
Support type: Scholarships in Brazil - Master